Suppr超能文献

在血管腔内主动脉瘤修复术中,副肾动脉能够被安全覆盖吗?

Can an accessory renal artery be safely covered during endovascular aortic aneurysm repair?

作者信息

Antoniou George A, Karkos Christos D, Antoniou Stavros A, Georgiadis George S

机构信息

Department of Vascular Surgery, Hellenic Red Cross Hospital, Athens, Greece.

出版信息

Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):1025-7. doi: 10.1093/icvts/ivt382. Epub 2013 Aug 21.

Abstract

A best evidence topic was constructed according to a structured protocol. The question addressed was whether coverage of an accessory renal artery (ARA) in patients undergoing endovascular aortic aneurysm repair (EVAR) is associated with increased risk of renal impairment. Altogether, 106 papers were located using the reported searches, of which 5 represented the best evidence to answer the question. The authors, journal, date and country of publication, study type, patient group studied, relevant outcomes parameters and results of these papers are tabulated. Our best evidence analysis included 116 patients who had one or more ARA excluded during EVAR. Segmental renal infarction occurred in varying numbers of patients (ranging from 0 to 84%). The authors consistently demonstrate that loss of renal mass is not associated with functional renal impairment, expressed by various outcome parameters such as serum creatinine, glomerular filtration rate (GFR), renal failure requiring dialysis and worsening hypertension. Comparisons of groups of patient with covered or preserved ARAs by one of the selected studies showed no difference in any of these renal outcome parameters, apart from a significantly higher renal infarct volume in the former group (P < 0.001). Subgroup analysis of patients with pre-existing renal dysfunction (GFR < 60 ml/h/m(2)) showed no difference in GFR change when comparing covered with uncovered ARA patient cohorts. No type II endoleak related to the covered ARA was reported in any of these studies. In conclusion, current evidence supports the safety of coverage of ARAs located in the proximal fixation zone to achieve seal in EVAR.

摘要

根据结构化方案构建了一个最佳证据主题。所探讨的问题是,接受血管内主动脉瘤修复术(EVAR)的患者中,副肾动脉(ARA)的覆盖是否与肾功能损害风险增加相关。通过报告的检索共找到106篇论文,其中5篇代表回答该问题的最佳证据。现将这些论文的作者、期刊、出版日期和国家、研究类型、所研究的患者群体、相关结局参数及结果制成表格。我们的最佳证据分析纳入了116例在EVAR期间有一条或多条ARA被排除的患者。不同数量的患者发生了节段性肾梗死(范围从0至84%)。作者一致表明,肾实质丢失与功能性肾功能损害无关,功能性肾功能损害由血清肌酐、肾小球滤过率(GFR)、需要透析的肾衰竭及高血压恶化等各种结局参数来表示。一项入选研究对覆盖或保留ARA的患者组进行比较,结果显示除前一组肾梗死体积显著更高外(P<0.001),这些肾功能结局参数在两组间均无差异。对已有肾功能不全(GFR<60 ml/h/m²)的患者进行亚组分析显示,比较覆盖与未覆盖ARA的患者队列时,GFR变化无差异。这些研究均未报告与被覆盖ARA相关的II型内漏。总之,目前的证据支持在EVAR中覆盖位于近端固定区的ARA以实现密封的安全性。

相似文献

本文引用的文献

3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验